These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 15053925)
1. Overexpression of receptor of advanced glycation end products hypersensitizes cells for amyloid beta peptide-induced cell death. Hadding A; Kaltschmidt B; Kaltschmidt C Biochim Biophys Acta; 2004 Apr; 1691(1):67-72. PubMed ID: 15053925 [TBL] [Abstract][Full Text] [Related]
2. RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling. Chaney MO; Stine WB; Kokjohn TA; Kuo YM; Esh C; Rahman A; Luehrs DC; Schmidt AM; Stern D; Yan SD; Roher AE Biochim Biophys Acta; 2005 Jun; 1741(1-2):199-205. PubMed ID: 15882940 [TBL] [Abstract][Full Text] [Related]
3. Geniposide attenuates oligomeric Aβ(1-42)-induced inflammatory response by targeting RAGE-dependent signaling in BV2 cells. Lv C; Wang L; Liu X; Cong X; Yan SS; Wang Y; Zhang W Curr Alzheimer Res; 2014; 11(5):430-40. PubMed ID: 24801214 [TBL] [Abstract][Full Text] [Related]
4. Immunodistribution of amyloid beta protein (Aβ) and advanced glycation end-product receptors (RAGE) in choroid plexus and ependyma of resuscitated patients. Maślińska D; Laure-Kamionowska M; Taraszewska A; Deręgowski K; Maśliński S Folia Neuropathol; 2011; 49(4):295-300. PubMed ID: 22212919 [TBL] [Abstract][Full Text] [Related]
5. S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses. Businaro R; Leone S; Fabrizi C; Sorci G; Donato R; Lauro GM; Fumagalli L J Neurosci Res; 2006 Apr; 83(5):897-906. PubMed ID: 16477616 [TBL] [Abstract][Full Text] [Related]
6. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model. Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646 [TBL] [Abstract][Full Text] [Related]
7. Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway. Chen C; Li XH; Tu Y; Sun HT; Liang HQ; Cheng SX; Zhang S Neuroscience; 2014 Jan; 257():1-10. PubMed ID: 24188791 [TBL] [Abstract][Full Text] [Related]
8. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products. Mruthinti S; Sood A; Humphrey CL; Swamy-Mruthinti S; Buccafusco JJ Neuroscience; 2006 Oct; 142(2):463-73. PubMed ID: 16890367 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxic role of advanced glycation end-products in PC12 cells treated with β‑amyloid peptide. Yan FL; Han GL; Wu GJ Mol Med Rep; 2013 Aug; 8(2):367-72. PubMed ID: 23799541 [TBL] [Abstract][Full Text] [Related]
10. On the in vivo early toxic properties of A-beta 25-35 peptide in the rat hippocampus: involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression. Cuevas E; Lantz SM; Tobón-Velasco JC; Newport GD; Wu Q; Virmani A; Ali SF; Santamaría A Neurotoxicol Teratol; 2011; 33(2):288-96. PubMed ID: 21216281 [TBL] [Abstract][Full Text] [Related]
11. RAGE mediated intracellular Aβ uptake contributes to the breakdown of tight junction in retinal pigment epithelium. Park SW; Kim JH; Park SM; Moon M; Lee KH; Park KH; Park WJ; Kim JH Oncotarget; 2015 Nov; 6(34):35263-73. PubMed ID: 26431165 [TBL] [Abstract][Full Text] [Related]
12. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. Li M; Shang DS; Zhao WD; Tian L; Li B; Fang WG; Zhu L; Man SM; Chen YH J Immunol; 2009 May; 182(9):5778-88. PubMed ID: 19380826 [TBL] [Abstract][Full Text] [Related]
13. Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage. Li H; Wu W; Sun Q; Liu M; Li W; Zhang XS; Zhou ML; Hang CH Brain Res; 2014 Jan; 1543():315-23. PubMed ID: 24291745 [TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta mediates the receptor of advanced glycation end product-induced pro-inflammatory response via toll-like receptor 4 signaling pathway in retinal ganglion cell line RGC-5. Lee JJ; Wang PW; Yang IH; Wu CL; Chuang JH Int J Biochem Cell Biol; 2015 Jul; 64():1-10. PubMed ID: 25783987 [TBL] [Abstract][Full Text] [Related]
15. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). Raucci A; Cugusi S; Antonelli A; Barabino SM; Monti L; Bierhaus A; Reiss K; Saftig P; Bianchi ME FASEB J; 2008 Oct; 22(10):3716-27. PubMed ID: 18603587 [TBL] [Abstract][Full Text] [Related]
16. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Lu C; He JC; Cai W; Liu H; Zhu L; Vlassara H Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11767-72. PubMed ID: 15289604 [TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Du Yan S; Zhu H; Fu J; Yan SF; Roher A; Tourtellotte WW; Rajavashisth T; Chen X; Godman GC; Stern D; Schmidt AM Proc Natl Acad Sci U S A; 1997 May; 94(10):5296-301. PubMed ID: 9144231 [TBL] [Abstract][Full Text] [Related]
18. Two β-strands of RAGE participate in the recognition and transport of amyloid-β peptide across the blood brain barrier. Kim SJ; Ahn JW; Kim H; Ha HJ; Lee SW; Kim HK; Lee S; Hong HS; Kim YH; Choi CY Biochem Biophys Res Commun; 2013 Sep; 439(2):252-7. PubMed ID: 23973487 [TBL] [Abstract][Full Text] [Related]
19. cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein. Malherbe P; Richards JG; Gaillard H; Thompson A; Diener C; Schuler A; Huber G Brain Res Mol Brain Res; 1999 Aug; 71(2):159-70. PubMed ID: 10521570 [TBL] [Abstract][Full Text] [Related]